nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—MPO—Carboplatin—breast cancer	0.29	1	CbGbCtD
Cefaclor—MPO—IL23-mediated signaling events—IL24—breast cancer	0.00443	0.0478	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—ETS2—breast cancer	0.00278	0.0299	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—SHMT1—breast cancer	0.00255	0.0275	CbGpPWpGaD
Cefaclor—SLC15A2—mammary gland—breast cancer	0.00192	0.0981	CbGeAlD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00185	0.0199	CbGpPWpGaD
Cefaclor—Carbenicillin—PLA2G4A—breast cancer	0.00176	0.367	CrCbGaD
Cefaclor—MPO—C-MYB transcription factor network—PIM1—breast cancer	0.00174	0.0188	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00171	0.0185	CbGpPWpGaD
Cefaclor—SLC15A1—epithelium—breast cancer	0.00171	0.0874	CbGeAlD
Cefaclor—MPO—Folate Metabolism—GPX2—breast cancer	0.0016	0.0173	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—GPX4—breast cancer	0.00158	0.0171	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—CSF1—breast cancer	0.00155	0.0167	CbGpPWpGaD
Cefaclor—MPO—epithelium—breast cancer	0.00154	0.0786	CbGeAlD
Cefaclor—MPO—Vitamin B12 Metabolism—MTR—breast cancer	0.00153	0.0165	CbGpPWpGaD
Cefaclor—SLC15A1—endometrium—breast cancer	0.00153	0.0783	CbGeAlD
Cefaclor—MPO—Vitamin B12 Metabolism—HBA1—breast cancer	0.00149	0.0161	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CSF1R—breast cancer	0.00148	0.016	CbGpPWpGaD
Cefaclor—MPO—skin of body—breast cancer	0.00146	0.0748	CbGeAlD
Cefaclor—MPO—IL23-mediated signaling events—STAT5A—breast cancer	0.00128	0.0137	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—GPX2—breast cancer	0.00127	0.0137	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—GPX4—breast cancer	0.00126	0.0135	CbGpPWpGaD
Cefaclor—MPO—pituitary gland—breast cancer	0.00125	0.0638	CbGeAlD
Cefaclor—MPO—Folate Metabolism—MTR—breast cancer	0.00125	0.0134	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—HBA1—breast cancer	0.00122	0.0131	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CD34—breast cancer	0.00121	0.013	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—TAB2—breast cancer	0.00113	0.0122	CbGpPWpGaD
Cefaclor—MPO—adrenal gland—breast cancer	0.00111	0.057	CbGeAlD
Cefaclor—MPO—Vitamin B12 Metabolism—PLG—breast cancer	0.00108	0.0116	CbGpPWpGaD
Cefaclor—MPO—bone marrow—breast cancer	0.00108	0.0551	CbGeAlD
Cefaclor—SLC15A1—endocrine gland—breast cancer	0.00107	0.0549	CbGeAlD
Cefaclor—MPO—C-MYB transcription factor network—WNT1—breast cancer	0.00106	0.0114	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—MTR—breast cancer	0.00099	0.0107	CbGpPWpGaD
Cefaclor—MPO—endocrine gland—breast cancer	0.000966	0.0494	CbGeAlD
Cefaclor—MPO—Selenium Micronutrient Network—HBA1—breast cancer	0.000965	0.0104	CbGpPWpGaD
Cefaclor—SLC15A2—endometrium—breast cancer	0.000957	0.049	CbGeAlD
Cefaclor—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000951	0.0102	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—SOD2—breast cancer	0.000932	0.01	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—NFKBIA—breast cancer	0.00092	0.00991	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—NOS2—breast cancer	0.00092	0.00991	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000903	0.00972	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—GATA3—breast cancer	0.000899	0.00968	CbGpPWpGaD
Cefaclor—Benzylpenicillin—SLCO1B1—breast cancer	0.000886	0.185	CrCbGaD
Cefaclor—MPO—Selenium Micronutrient Network—PTGS1—breast cancer	0.000883	0.00951	CbGpPWpGaD
Cefaclor—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000882	0.0095	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—PLG—breast cancer	0.000878	0.00946	CbGpPWpGaD
Cefaclor—SLC15A2—pituitary gland—breast cancer	0.000866	0.0443	CbGeAlD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000838	0.00902	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000826	0.00889	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000826	0.00889	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—MTHFR—breast cancer	0.000821	0.00884	CbGpPWpGaD
Cefaclor—SLC15A2—female reproductive system—breast cancer	0.000793	0.0406	CbGeAlD
Cefaclor—SLC15A2—adrenal gland—breast cancer	0.000774	0.0396	CbGeAlD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000766	0.00825	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000766	0.00825	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—SOD2—breast cancer	0.000758	0.00816	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—GPX1—breast cancer	0.000723	0.00779	CbGpPWpGaD
Cefaclor—SLC15A2—female gonad—breast cancer	0.000722	0.0369	CbGeAlD
Cefaclor—MPO—IL23-mediated signaling events—IFNG—breast cancer	0.000706	0.0076	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—PLG—breast cancer	0.000698	0.00751	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—RELA—breast cancer	0.000696	0.0075	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000684	0.00737	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—CD4—breast cancer	0.000682	0.00734	CbGpPWpGaD
Cefaclor—SLC15A2—endocrine gland—breast cancer	0.000671	0.0343	CbGeAlD
Cefaclor—MPO—lymph node—breast cancer	0.000668	0.0342	CbGeAlD
Cefaclor—MPO—Folate Metabolism—MTHFR—breast cancer	0.000668	0.00719	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000635	0.00684	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL1B—breast cancer	0.000629	0.00678	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL2—breast cancer	0.000627	0.00675	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—HES1—breast cancer	0.000626	0.00675	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000626	0.00674	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—NCOR1—breast cancer	0.000623	0.00671	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—GSTM1—breast cancer	0.000623	0.00671	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—SOD2—breast cancer	0.000602	0.00649	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000602	0.00649	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000602	0.00649	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—SERPINE1—breast cancer	0.000599	0.00645	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—ALB—breast cancer	0.000598	0.00644	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000581	0.00625	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—GPX1—breast cancer	0.000575	0.00619	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.00056	0.00603	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000559	0.00602	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000559	0.00602	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—IFNG—breast cancer	0.000546	0.00588	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—RELA—breast cancer	0.000539	0.0058	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—MTHFR—breast cancer	0.00053	0.00571	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—STAT3—breast cancer	0.000528	0.00568	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000519	0.00559	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000518	0.00558	CbGpPWpGaD
Cefaclor—Cefpiramide—ALB—breast cancer	0.000496	0.103	CrCbGaD
Cefaclor—MPO—Folate Metabolism—SERPINE1—breast cancer	0.000488	0.00525	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—IL1B—breast cancer	0.000487	0.00524	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—ALB—breast cancer	0.000487	0.00524	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000481	0.00518	CbGpPWpGaD
Cefaclor—SLC15A2—lymph node—breast cancer	0.000464	0.0237	CbGeAlD
Cefaclor—MPO—C-MYB transcription factor network—KIT—breast cancer	0.000462	0.00498	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000459	0.00494	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—TNF—breast cancer	0.000457	0.00492	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—IFNG—breast cancer	0.000444	0.00478	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—RELA—breast cancer	0.000438	0.00472	CbGpPWpGaD
Cefaclor—Cefonicid—ALB—breast cancer	0.000432	0.0901	CrCbGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000426	0.00458	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.00042	0.00452	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.00042	0.00452	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—PIK3CA—breast cancer	0.000416	0.00448	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—IL1B—breast cancer	0.000396	0.00427	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—IL2—breast cancer	0.000395	0.00425	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000389	0.00419	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000389	0.00419	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—SERPINE1—breast cancer	0.000387	0.00417	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—ALB—breast cancer	0.000387	0.00416	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—BCL2—breast cancer	0.00037	0.00398	CbGpPWpGaD
Cefaclor—MPO—IL23-mediated signaling events—IL6—breast cancer	0.000369	0.00397	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CD4—breast cancer	0.000354	0.00381	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—TNF—breast cancer	0.000353	0.0038	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—IFNG—breast cancer	0.000353	0.0038	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—PTGS2—breast cancer	0.000351	0.00378	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—RELA—breast cancer	0.000348	0.00375	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000348	0.00374	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000348	0.00374	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—PTGS2—breast cancer	0.000338	0.00364	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CDKN1B—breast cancer	0.000333	0.00358	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000323	0.00347	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000323	0.00347	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000318	0.00342	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CCND1—breast cancer	0.000317	0.00342	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—IL1B—breast cancer	0.000315	0.00339	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000312	0.00336	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—CDKN1A—breast cancer	0.000307	0.0033	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000306	0.0033	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000306	0.0033	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000295	0.00318	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000289	0.00312	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—TNF—breast cancer	0.000287	0.0031	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—IL6—breast cancer	0.000285	0.00307	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000284	0.00306	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000284	0.00306	CbGpPWpGaD
Cefaclor—Cefradine—CYP3A4—breast cancer	0.00028	0.0583	CrCbGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000263	0.00284	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—MYC—breast cancer	0.000254	0.00274	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—TP53—breast cancer	0.000253	0.00273	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.00025	0.00269	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000245	0.00263	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000242	0.0026	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000241	0.00259	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—KRAS—breast cancer	0.000235	0.00253	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000232	0.0025	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—IL6—breast cancer	0.000232	0.0025	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—TNF—breast cancer	0.000228	0.00246	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000224	0.00241	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000224	0.00241	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000224	0.00241	CbGpPWpGaD
Cefaclor—Ampicillin—ALB—breast cancer	0.000216	0.0451	CrCbGaD
Cefaclor—Cephalexin—CYP2D6—breast cancer	0.000211	0.044	CrCbGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000208	0.00224	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—HRAS—breast cancer	0.0002	0.00215	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.00019	0.00205	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—IL6—breast cancer	0.000184	0.00198	CbGpPWpGaD
Cefaclor—Cephalexin—CYP3A4—breast cancer	0.000181	0.0377	CrCbGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000177	0.0019	CbGpPWpGaD
Cefaclor—Cefalotin—ALB—breast cancer	0.000174	0.0362	CrCbGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000159	0.00171	CbGpPWpGaD
Cefaclor—Cephalexin—ALB—breast cancer	0.000158	0.0329	CrCbGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000155	0.00167	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000147	0.00158	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000144	0.00155	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000138	0.00149	CbGpPWpGaD
Cefaclor—Body temperature increased—Paclitaxel—breast cancer	0.000133	0.000225	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000133	0.00143	CbGpPWpGaD
Cefaclor—Urethral disorder—Epirubicin—breast cancer	0.000133	0.000225	CcSEcCtD
Cefaclor—Hepatobiliary disease—Doxorubicin—breast cancer	0.000132	0.000223	CcSEcCtD
Cefaclor—Epistaxis—Doxorubicin—breast cancer	0.000132	0.000223	CcSEcCtD
Cefaclor—Anorexia—Capecitabine—breast cancer	0.000132	0.000223	CcSEcCtD
Cefaclor—Vomiting—Mitoxantrone—breast cancer	0.000132	0.000222	CcSEcCtD
Cefaclor—Vomiting—Irinotecan—breast cancer	0.000132	0.000222	CcSEcCtD
Cefaclor—Sinusitis—Doxorubicin—breast cancer	0.000131	0.000222	CcSEcCtD
Cefaclor—Immune system disorder—Methotrexate—breast cancer	0.000131	0.000221	CcSEcCtD
Cefaclor—Dizziness—Fluorouracil—breast cancer	0.000131	0.000221	CcSEcCtD
Cefaclor—Agranulocytosis—Doxorubicin—breast cancer	0.000131	0.00022	CcSEcCtD
Cefaclor—Rash—Mitoxantrone—breast cancer	0.00013	0.00022	CcSEcCtD
Cefaclor—Rash—Irinotecan—breast cancer	0.00013	0.00022	CcSEcCtD
Cefaclor—Dermatitis—Irinotecan—breast cancer	0.00013	0.00022	CcSEcCtD
Cefaclor—Dermatitis—Mitoxantrone—breast cancer	0.00013	0.00022	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Docetaxel—breast cancer	0.00013	0.00022	CcSEcCtD
Cefaclor—Chills—Methotrexate—breast cancer	0.00013	0.00022	CcSEcCtD
Cefaclor—Headache—Mitoxantrone—breast cancer	0.00013	0.000219	CcSEcCtD
Cefaclor—Headache—Irinotecan—breast cancer	0.00013	0.000219	CcSEcCtD
Cefaclor—Hypotension—Capecitabine—breast cancer	0.000129	0.000218	CcSEcCtD
Cefaclor—Insomnia—Docetaxel—breast cancer	0.000129	0.000218	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000128	0.00138	CbGpPWpGaD
Cefaclor—Paraesthesia—Docetaxel—breast cancer	0.000128	0.000217	CcSEcCtD
Cefaclor—Erythema multiforme—Epirubicin—breast cancer	0.000128	0.000217	CcSEcCtD
Cefaclor—Vomiting—Gemcitabine—breast cancer	0.000128	0.000216	CcSEcCtD
Cefaclor—Dyspnoea—Docetaxel—breast cancer	0.000128	0.000215	CcSEcCtD
Cefaclor—Somnolence—Docetaxel—breast cancer	0.000127	0.000214	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000127	0.00137	CbGpPWpGaD
Cefaclor—Rash—Gemcitabine—breast cancer	0.000127	0.000214	CcSEcCtD
Cefaclor—Dermatitis—Gemcitabine—breast cancer	0.000127	0.000214	CcSEcCtD
Cefaclor—Haemoglobin—Doxorubicin—breast cancer	0.000126	0.000213	CcSEcCtD
Cefaclor—Headache—Gemcitabine—breast cancer	0.000126	0.000213	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000126	0.000213	CcSEcCtD
Cefaclor—Vomiting—Fluorouracil—breast cancer	0.000126	0.000213	CcSEcCtD
Cefaclor—Rhinitis—Doxorubicin—breast cancer	0.000126	0.000212	CcSEcCtD
Cefaclor—Dyspepsia—Docetaxel—breast cancer	0.000126	0.000212	CcSEcCtD
Cefaclor—Haemorrhage—Doxorubicin—breast cancer	0.000126	0.000212	CcSEcCtD
Cefaclor—Hepatitis—Doxorubicin—breast cancer	0.000126	0.000212	CcSEcCtD
Cefaclor—Insomnia—Capecitabine—breast cancer	0.000125	0.000211	CcSEcCtD
Cefaclor—Rash—Fluorouracil—breast cancer	0.000125	0.000211	CcSEcCtD
Cefaclor—Dermatitis—Fluorouracil—breast cancer	0.000125	0.000211	CcSEcCtD
Cefaclor—Paraesthesia—Capecitabine—breast cancer	0.000124	0.00021	CcSEcCtD
Cefaclor—Decreased appetite—Docetaxel—breast cancer	0.000124	0.00021	CcSEcCtD
Cefaclor—Hypersensitivity—Paclitaxel—breast cancer	0.000124	0.00021	CcSEcCtD
Cefaclor—Headache—Fluorouracil—breast cancer	0.000124	0.000209	CcSEcCtD
Cefaclor—Urinary tract disorder—Doxorubicin—breast cancer	0.000124	0.000209	CcSEcCtD
Cefaclor—Oedema peripheral—Doxorubicin—breast cancer	0.000124	0.000209	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000124	0.00133	CbGpPWpGaD
Cefaclor—Gastrointestinal disorder—Docetaxel—breast cancer	0.000123	0.000208	CcSEcCtD
Cefaclor—Dyspnoea—Capecitabine—breast cancer	0.000123	0.000208	CcSEcCtD
Cefaclor—Urethral disorder—Doxorubicin—breast cancer	0.000123	0.000208	CcSEcCtD
Cefaclor—Nausea—Irinotecan—breast cancer	0.000123	0.000207	CcSEcCtD
Cefaclor—Nausea—Mitoxantrone—breast cancer	0.000123	0.000207	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000123	0.00132	CbGpPWpGaD
Cefaclor—Immune system disorder—Epirubicin—breast cancer	0.000123	0.000207	CcSEcCtD
Cefaclor—Constipation—Docetaxel—breast cancer	0.000122	0.000206	CcSEcCtD
Cefaclor—Pain—Docetaxel—breast cancer	0.000122	0.000206	CcSEcCtD
Cefaclor—Back pain—Methotrexate—breast cancer	0.000122	0.000206	CcSEcCtD
Cefaclor—Dyspepsia—Capecitabine—breast cancer	0.000122	0.000206	CcSEcCtD
Cefaclor—Chills—Epirubicin—breast cancer	0.000122	0.000206	CcSEcCtD
Cefaclor—Asthenia—Paclitaxel—breast cancer	0.000121	0.000204	CcSEcCtD
Cefaclor—Decreased appetite—Capecitabine—breast cancer	0.00012	0.000203	CcSEcCtD
Cefaclor—Nausea—Gemcitabine—breast cancer	0.00012	0.000202	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Capecitabine—breast cancer	0.00012	0.000202	CcSEcCtD
Cefaclor—Pruritus—Paclitaxel—breast cancer	0.000119	0.000201	CcSEcCtD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	0.000119	0.00128	CbGpPWpGaD
Cefaclor—Erythema multiforme—Doxorubicin—breast cancer	0.000119	0.0002	CcSEcCtD
Cefaclor—Pain—Capecitabine—breast cancer	0.000118	0.0002	CcSEcCtD
Cefaclor—Constipation—Capecitabine—breast cancer	0.000118	0.0002	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000118	0.00127	CbGpPWpGaD
Cefaclor—Feeling abnormal—Docetaxel—breast cancer	0.000118	0.000199	CcSEcCtD
Cefaclor—Nausea—Fluorouracil—breast cancer	0.000118	0.000199	CcSEcCtD
Cefaclor—Ill-defined disorder—Methotrexate—breast cancer	0.000117	0.000198	CcSEcCtD
Cefaclor—Gastrointestinal pain—Docetaxel—breast cancer	0.000117	0.000197	CcSEcCtD
Cefaclor—Flatulence—Epirubicin—breast cancer	0.000116	0.000196	CcSEcCtD
Cefaclor—Tension—Epirubicin—breast cancer	0.000116	0.000196	CcSEcCtD
Cefaclor—Diarrhoea—Paclitaxel—breast cancer	0.000115	0.000195	CcSEcCtD
Cefaclor—Nervousness—Epirubicin—breast cancer	0.000115	0.000194	CcSEcCtD
Cefaclor—Back pain—Epirubicin—breast cancer	0.000114	0.000193	CcSEcCtD
Cefaclor—Feeling abnormal—Capecitabine—breast cancer	0.000114	0.000193	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000114	0.00123	CbGpPWpGaD
Cefaclor—Malaise—Methotrexate—breast cancer	0.000114	0.000192	CcSEcCtD
Cefaclor—Immune system disorder—Doxorubicin—breast cancer	0.000113	0.000191	CcSEcCtD
Cefaclor—Vertigo—Methotrexate—breast cancer	0.000113	0.000191	CcSEcCtD
Cefaclor—Gastrointestinal pain—Capecitabine—breast cancer	0.000113	0.000191	CcSEcCtD
Cefaclor—Abdominal pain—Docetaxel—breast cancer	0.000113	0.000191	CcSEcCtD
Cefaclor—Body temperature increased—Docetaxel—breast cancer	0.000113	0.000191	CcSEcCtD
Cefaclor—Leukopenia—Methotrexate—breast cancer	0.000113	0.000191	CcSEcCtD
Cefaclor—Chills—Doxorubicin—breast cancer	0.000113	0.00019	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000112	0.00121	CbGpPWpGaD
Cefaclor—Dizziness—Paclitaxel—breast cancer	0.000112	0.000188	CcSEcCtD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.000111	0.00119	CbGpPWpGaD
Cefaclor—Cough—Methotrexate—breast cancer	0.00011	0.000186	CcSEcCtD
Cefaclor—Urticaria—Capecitabine—breast cancer	0.00011	0.000186	CcSEcCtD
Cefaclor—Ill-defined disorder—Epirubicin—breast cancer	0.00011	0.000185	CcSEcCtD
Cefaclor—Abdominal pain—Capecitabine—breast cancer	0.000109	0.000185	CcSEcCtD
Cefaclor—Body temperature increased—Capecitabine—breast cancer	0.000109	0.000185	CcSEcCtD
Cefaclor—Convulsion—Methotrexate—breast cancer	0.000109	0.000185	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	0.000109	0.00118	CbGpPWpGaD
Cefaclor—Agitation—Epirubicin—breast cancer	0.000109	0.000183	CcSEcCtD
Cefaclor—Flatulence—Doxorubicin—breast cancer	0.000108	0.000182	CcSEcCtD
Cefaclor—Chest pain—Methotrexate—breast cancer	0.000108	0.000181	CcSEcCtD
Cefaclor—Myalgia—Methotrexate—breast cancer	0.000108	0.000181	CcSEcCtD
Cefaclor—Arthralgia—Methotrexate—breast cancer	0.000108	0.000181	CcSEcCtD
Cefaclor—Tension—Doxorubicin—breast cancer	0.000107	0.000181	CcSEcCtD
Cefaclor—Vomiting—Paclitaxel—breast cancer	0.000107	0.000181	CcSEcCtD
Cefaclor—Malaise—Epirubicin—breast cancer	0.000107	0.00018	CcSEcCtD
Cefaclor—Rash—Paclitaxel—breast cancer	0.000106	0.000179	CcSEcCtD
Cefaclor—Dermatitis—Paclitaxel—breast cancer	0.000106	0.000179	CcSEcCtD
Cefaclor—Discomfort—Methotrexate—breast cancer	0.000106	0.000179	CcSEcCtD
Cefaclor—Nervousness—Doxorubicin—breast cancer	0.000106	0.000179	CcSEcCtD
Cefaclor—Vertigo—Epirubicin—breast cancer	0.000106	0.000179	CcSEcCtD
Cefaclor—Syncope—Epirubicin—breast cancer	0.000106	0.000179	CcSEcCtD
Cefaclor—Leukopenia—Epirubicin—breast cancer	0.000106	0.000178	CcSEcCtD
Cefaclor—Back pain—Doxorubicin—breast cancer	0.000106	0.000178	CcSEcCtD
Cefaclor—Headache—Paclitaxel—breast cancer	0.000106	0.000178	CcSEcCtD
Cefaclor—Hypersensitivity—Docetaxel—breast cancer	0.000105	0.000178	CcSEcCtD
Cefaclor—Palpitations—Epirubicin—breast cancer	0.000104	0.000176	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000104	0.00112	CbGpPWpGaD
Cefaclor—Confusional state—Methotrexate—breast cancer	0.000104	0.000175	CcSEcCtD
Cefaclor—Loss of consciousness—Epirubicin—breast cancer	0.000104	0.000175	CcSEcCtD
Cefaclor—Cough—Epirubicin—breast cancer	0.000103	0.000174	CcSEcCtD
Cefaclor—Anaphylactic shock—Methotrexate—breast cancer	0.000103	0.000174	CcSEcCtD
Cefaclor—Asthenia—Docetaxel—breast cancer	0.000103	0.000173	CcSEcCtD
Cefaclor—Convulsion—Epirubicin—breast cancer	0.000102	0.000173	CcSEcCtD
Cefaclor—Hypersensitivity—Capecitabine—breast cancer	0.000102	0.000172	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000102	0.00109	CbGpPWpGaD
Cefaclor—Ill-defined disorder—Doxorubicin—breast cancer	0.000101	0.000171	CcSEcCtD
Cefaclor—Pruritus—Docetaxel—breast cancer	0.000101	0.000171	CcSEcCtD
Cefaclor—Nervous system disorder—Methotrexate—breast cancer	0.000101	0.000171	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000101	0.00109	CbGpPWpGaD
Cefaclor—Thrombocytopenia—Methotrexate—breast cancer	0.000101	0.00017	CcSEcCtD
Cefaclor—Myalgia—Epirubicin—breast cancer	0.000101	0.00017	CcSEcCtD
Cefaclor—Arthralgia—Epirubicin—breast cancer	0.000101	0.00017	CcSEcCtD
Cefaclor—Chest pain—Epirubicin—breast cancer	0.000101	0.00017	CcSEcCtD
Cefaclor—Agitation—Doxorubicin—breast cancer	0.000101	0.00017	CcSEcCtD
Cefaclor—Anxiety—Epirubicin—breast cancer	0.0001	0.000169	CcSEcCtD
Cefaclor—Nausea—Paclitaxel—breast cancer	0.0001	0.000169	CcSEcCtD
Cefaclor—Hyperhidrosis—Methotrexate—breast cancer	9.97e-05	0.000168	CcSEcCtD
Cefaclor—Discomfort—Epirubicin—breast cancer	9.94e-05	0.000168	CcSEcCtD
Cefaclor—Asthenia—Capecitabine—breast cancer	9.94e-05	0.000168	CcSEcCtD
Cefaclor—Malaise—Doxorubicin—breast cancer	9.86e-05	0.000166	CcSEcCtD
Cefaclor—Vertigo—Doxorubicin—breast cancer	9.83e-05	0.000166	CcSEcCtD
Cefaclor—Anorexia—Methotrexate—breast cancer	9.83e-05	0.000166	CcSEcCtD
Cefaclor—Syncope—Doxorubicin—breast cancer	9.81e-05	0.000165	CcSEcCtD
Cefaclor—Pruritus—Capecitabine—breast cancer	9.8e-05	0.000165	CcSEcCtD
Cefaclor—Leukopenia—Doxorubicin—breast cancer	9.79e-05	0.000165	CcSEcCtD
Cefaclor—Diarrhoea—Docetaxel—breast cancer	9.79e-05	0.000165	CcSEcCtD
Cefaclor—Confusional state—Epirubicin—breast cancer	9.73e-05	0.000164	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	9.69e-05	0.00104	CbGpPWpGaD
Cefaclor—Palpitations—Doxorubicin—breast cancer	9.67e-05	0.000163	CcSEcCtD
Cefaclor—Anaphylactic shock—Epirubicin—breast cancer	9.65e-05	0.000163	CcSEcCtD
Cefaclor—Oedema—Epirubicin—breast cancer	9.65e-05	0.000163	CcSEcCtD
Cefaclor—Hypotension—Methotrexate—breast cancer	9.63e-05	0.000162	CcSEcCtD
Cefaclor—Loss of consciousness—Doxorubicin—breast cancer	9.61e-05	0.000162	CcSEcCtD
Cefaclor—Cough—Doxorubicin—breast cancer	9.54e-05	0.000161	CcSEcCtD
Cefaclor—Shock—Epirubicin—breast cancer	9.49e-05	0.00016	CcSEcCtD
Cefaclor—Convulsion—Doxorubicin—breast cancer	9.48e-05	0.00016	CcSEcCtD
Cefaclor—Diarrhoea—Capecitabine—breast cancer	9.48e-05	0.00016	CcSEcCtD
Cefaclor—Nervous system disorder—Epirubicin—breast cancer	9.46e-05	0.00016	CcSEcCtD
Cefaclor—Dizziness—Docetaxel—breast cancer	9.46e-05	0.00016	CcSEcCtD
Cefaclor—Thrombocytopenia—Epirubicin—breast cancer	9.45e-05	0.000159	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methotrexate—breast cancer	9.39e-05	0.000158	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	9.37e-05	0.00101	CbGpPWpGaD
Cefaclor—Hyperhidrosis—Epirubicin—breast cancer	9.33e-05	0.000157	CcSEcCtD
Cefaclor—Insomnia—Methotrexate—breast cancer	9.32e-05	0.000157	CcSEcCtD
Cefaclor—Myalgia—Doxorubicin—breast cancer	9.31e-05	0.000157	CcSEcCtD
Cefaclor—Arthralgia—Doxorubicin—breast cancer	9.31e-05	0.000157	CcSEcCtD
Cefaclor—Chest pain—Doxorubicin—breast cancer	9.31e-05	0.000157	CcSEcCtD
Cefaclor—Anxiety—Doxorubicin—breast cancer	9.28e-05	0.000157	CcSEcCtD
Cefaclor—Paraesthesia—Methotrexate—breast cancer	9.26e-05	0.000156	CcSEcCtD
Cefaclor—Discomfort—Doxorubicin—breast cancer	9.2e-05	0.000155	CcSEcCtD
Cefaclor—Anorexia—Epirubicin—breast cancer	9.2e-05	0.000155	CcSEcCtD
Cefaclor—Dyspnoea—Methotrexate—breast cancer	9.19e-05	0.000155	CcSEcCtD
Cefaclor—Somnolence—Methotrexate—breast cancer	9.16e-05	0.000155	CcSEcCtD
Cefaclor—Dizziness—Capecitabine—breast cancer	9.16e-05	0.000154	CcSEcCtD
Cefaclor—Vomiting—Docetaxel—breast cancer	9.09e-05	0.000153	CcSEcCtD
Cefaclor—Dyspepsia—Methotrexate—breast cancer	9.07e-05	0.000153	CcSEcCtD
Cefaclor—Rash—Docetaxel—breast cancer	9.02e-05	0.000152	CcSEcCtD
Cefaclor—Hypotension—Epirubicin—breast cancer	9.02e-05	0.000152	CcSEcCtD
Cefaclor—Dermatitis—Docetaxel—breast cancer	9.01e-05	0.000152	CcSEcCtD
Cefaclor—Confusional state—Doxorubicin—breast cancer	9e-05	0.000152	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	8.99e-05	0.000968	CbGpPWpGaD
Cefaclor—Decreased appetite—Methotrexate—breast cancer	8.96e-05	0.000151	CcSEcCtD
Cefaclor—Headache—Docetaxel—breast cancer	8.96e-05	0.000151	CcSEcCtD
Cefaclor—Oedema—Doxorubicin—breast cancer	8.93e-05	0.000151	CcSEcCtD
Cefaclor—Anaphylactic shock—Doxorubicin—breast cancer	8.93e-05	0.000151	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Methotrexate—breast cancer	8.9e-05	0.00015	CcSEcCtD
Cefaclor—Pain—Methotrexate—breast cancer	8.82e-05	0.000149	CcSEcCtD
Cefaclor—Vomiting—Capecitabine—breast cancer	8.81e-05	0.000149	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Epirubicin—breast cancer	8.79e-05	0.000148	CcSEcCtD
Cefaclor—Shock—Doxorubicin—breast cancer	8.78e-05	0.000148	CcSEcCtD
Cefaclor—Nervous system disorder—Doxorubicin—breast cancer	8.75e-05	0.000148	CcSEcCtD
Cefaclor—Thrombocytopenia—Doxorubicin—breast cancer	8.74e-05	0.000147	CcSEcCtD
Cefaclor—Rash—Capecitabine—breast cancer	8.73e-05	0.000147	CcSEcCtD
Cefaclor—Insomnia—Epirubicin—breast cancer	8.73e-05	0.000147	CcSEcCtD
Cefaclor—Dermatitis—Capecitabine—breast cancer	8.72e-05	0.000147	CcSEcCtD
Cefaclor—Headache—Capecitabine—breast cancer	8.68e-05	0.000146	CcSEcCtD
Cefaclor—Paraesthesia—Epirubicin—breast cancer	8.66e-05	0.000146	CcSEcCtD
Cefaclor—Hyperhidrosis—Doxorubicin—breast cancer	8.63e-05	0.000146	CcSEcCtD
Cefaclor—Dyspnoea—Epirubicin—breast cancer	8.6e-05	0.000145	CcSEcCtD
Cefaclor—Somnolence—Epirubicin—breast cancer	8.58e-05	0.000145	CcSEcCtD
Cefaclor—Anorexia—Doxorubicin—breast cancer	8.51e-05	0.000144	CcSEcCtD
Cefaclor—Nausea—Docetaxel—breast cancer	8.5e-05	0.000143	CcSEcCtD
Cefaclor—Feeling abnormal—Methotrexate—breast cancer	8.5e-05	0.000143	CcSEcCtD
Cefaclor—Dyspepsia—Epirubicin—breast cancer	8.49e-05	0.000143	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methotrexate—breast cancer	8.43e-05	0.000142	CcSEcCtD
Cefaclor—Decreased appetite—Epirubicin—breast cancer	8.39e-05	0.000141	CcSEcCtD
Cefaclor—Hypotension—Doxorubicin—breast cancer	8.34e-05	0.000141	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Epirubicin—breast cancer	8.33e-05	0.000141	CcSEcCtD
Cefaclor—Pain—Epirubicin—breast cancer	8.25e-05	0.000139	CcSEcCtD
Cefaclor—Constipation—Epirubicin—breast cancer	8.25e-05	0.000139	CcSEcCtD
Cefaclor—Nausea—Capecitabine—breast cancer	8.23e-05	0.000139	CcSEcCtD
Cefaclor—Urticaria—Methotrexate—breast cancer	8.19e-05	0.000138	CcSEcCtD
Cefaclor—Abdominal pain—Methotrexate—breast cancer	8.15e-05	0.000137	CcSEcCtD
Cefaclor—Body temperature increased—Methotrexate—breast cancer	8.15e-05	0.000137	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Doxorubicin—breast cancer	8.13e-05	0.000137	CcSEcCtD
Cefaclor—Insomnia—Doxorubicin—breast cancer	8.07e-05	0.000136	CcSEcCtD
Cefaclor—Paraesthesia—Doxorubicin—breast cancer	8.02e-05	0.000135	CcSEcCtD
Cefaclor—Dyspnoea—Doxorubicin—breast cancer	7.96e-05	0.000134	CcSEcCtD
Cefaclor—Feeling abnormal—Epirubicin—breast cancer	7.95e-05	0.000134	CcSEcCtD
Cefaclor—Somnolence—Doxorubicin—breast cancer	7.94e-05	0.000134	CcSEcCtD
Cefaclor—Gastrointestinal pain—Epirubicin—breast cancer	7.89e-05	0.000133	CcSEcCtD
Cefaclor—Dyspepsia—Doxorubicin—breast cancer	7.86e-05	0.000133	CcSEcCtD
Cefaclor—Decreased appetite—Doxorubicin—breast cancer	7.76e-05	0.000131	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Doxorubicin—breast cancer	7.71e-05	0.00013	CcSEcCtD
Cefaclor—Urticaria—Epirubicin—breast cancer	7.66e-05	0.000129	CcSEcCtD
Cefaclor—Constipation—Doxorubicin—breast cancer	7.63e-05	0.000129	CcSEcCtD
Cefaclor—Pain—Doxorubicin—breast cancer	7.63e-05	0.000129	CcSEcCtD
Cefaclor—Abdominal pain—Epirubicin—breast cancer	7.63e-05	0.000129	CcSEcCtD
Cefaclor—Body temperature increased—Epirubicin—breast cancer	7.63e-05	0.000129	CcSEcCtD
Cefaclor—Hypersensitivity—Methotrexate—breast cancer	7.6e-05	0.000128	CcSEcCtD
Cefaclor—Asthenia—Methotrexate—breast cancer	7.4e-05	0.000125	CcSEcCtD
Cefaclor—Feeling abnormal—Doxorubicin—breast cancer	7.36e-05	0.000124	CcSEcCtD
Cefaclor—Gastrointestinal pain—Doxorubicin—breast cancer	7.3e-05	0.000123	CcSEcCtD
Cefaclor—Pruritus—Methotrexate—breast cancer	7.29e-05	0.000123	CcSEcCtD
Cefaclor—Hypersensitivity—Epirubicin—breast cancer	7.11e-05	0.00012	CcSEcCtD
Cefaclor—Urticaria—Doxorubicin—breast cancer	7.09e-05	0.00012	CcSEcCtD
Cefaclor—Abdominal pain—Doxorubicin—breast cancer	7.06e-05	0.000119	CcSEcCtD
Cefaclor—Body temperature increased—Doxorubicin—breast cancer	7.06e-05	0.000119	CcSEcCtD
Cefaclor—Diarrhoea—Methotrexate—breast cancer	7.05e-05	0.000119	CcSEcCtD
Cefaclor—Asthenia—Epirubicin—breast cancer	6.92e-05	0.000117	CcSEcCtD
Cefaclor—Pruritus—Epirubicin—breast cancer	6.83e-05	0.000115	CcSEcCtD
Cefaclor—Dizziness—Methotrexate—breast cancer	6.82e-05	0.000115	CcSEcCtD
Cefaclor—Diarrhoea—Epirubicin—breast cancer	6.6e-05	0.000111	CcSEcCtD
Cefaclor—Hypersensitivity—Doxorubicin—breast cancer	6.58e-05	0.000111	CcSEcCtD
Cefaclor—Vomiting—Methotrexate—breast cancer	6.55e-05	0.000111	CcSEcCtD
Cefaclor—Rash—Methotrexate—breast cancer	6.5e-05	0.00011	CcSEcCtD
Cefaclor—Dermatitis—Methotrexate—breast cancer	6.49e-05	0.00011	CcSEcCtD
Cefaclor—Headache—Methotrexate—breast cancer	6.46e-05	0.000109	CcSEcCtD
Cefaclor—Asthenia—Doxorubicin—breast cancer	6.4e-05	0.000108	CcSEcCtD
Cefaclor—Dizziness—Epirubicin—breast cancer	6.38e-05	0.000108	CcSEcCtD
Cefaclor—Pruritus—Doxorubicin—breast cancer	6.32e-05	0.000107	CcSEcCtD
Cefaclor—Vomiting—Epirubicin—breast cancer	6.13e-05	0.000103	CcSEcCtD
Cefaclor—Nausea—Methotrexate—breast cancer	6.12e-05	0.000103	CcSEcCtD
Cefaclor—Diarrhoea—Doxorubicin—breast cancer	6.11e-05	0.000103	CcSEcCtD
Cefaclor—Rash—Epirubicin—breast cancer	6.08e-05	0.000103	CcSEcCtD
Cefaclor—Dermatitis—Epirubicin—breast cancer	6.08e-05	0.000103	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	6.06e-05	0.000653	CbGpPWpGaD
Cefaclor—Headache—Epirubicin—breast cancer	6.04e-05	0.000102	CcSEcCtD
Cefaclor—Dizziness—Doxorubicin—breast cancer	5.9e-05	9.96e-05	CcSEcCtD
Cefaclor—Nausea—Epirubicin—breast cancer	5.73e-05	9.67e-05	CcSEcCtD
Cefaclor—Vomiting—Doxorubicin—breast cancer	5.68e-05	9.57e-05	CcSEcCtD
Cefaclor—Rash—Doxorubicin—breast cancer	5.63e-05	9.49e-05	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	5.63e-05	0.000606	CbGpPWpGaD
Cefaclor—Dermatitis—Doxorubicin—breast cancer	5.62e-05	9.49e-05	CcSEcCtD
Cefaclor—Headache—Doxorubicin—breast cancer	5.59e-05	9.43e-05	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	5.48e-05	0.00059	CbGpPWpGaD
Cefaclor—Nausea—Doxorubicin—breast cancer	5.3e-05	8.94e-05	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	5.09e-05	0.000548	CbGpPWpGaD
